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Background
Anxiety and depressive disorders can be chronic and disabling.
Although there are effective treatments, only a fraction of those
impaired receive treatment. Predictors of treatment-seeking and
treatment receipt could be informative for initiatives aiming to
tackle the burden of untreated anxiety and depression.
Aims
To investigate sociodemographic characteristics associatedwith
treatment-seeking and treatment receipt.
Method
Two binary retrospective reports of lifetime treatment-seeking
(n = 44 810) and treatment receipt (n = 37 346) were regressed on
sociodemographic factors (age, gender, UK ethnic minority
background, educational attainment, household income,
neighbourhood deprivation and social isolation) and alternative
coping strategies (self-medication with alcohol/drugs and
self-help) in UK Biobank participants with lifetime generalised
anxiety or major depressive disorder. Analyses were also
stratified by gender.
Results
Treatment access was more likely in those who reported use of
self-help strategies, with university-level education and those
from less economically advantaged circumstances (household
income <£30 000 and greater neighbourhood deprivation).
Treatment access was less likely in those who were male, from a
UK ethnic minority background and with high household
incomes (>£100 000). Men who self-medicated and/or had a
vocational qualification were also less likely to seek treatment.
Conclusions
This work on retrospective reports of treatment-seeking and
treatment receipt at any time of life replicates known associa-
tions with treatment-seeking and treatment receipt during time
of treatment need. More work is required to understandwhether
improving rates of treatment-seeking improves prognostic out-
comes for individuals with anxiety or depression.
Keywords
Anxiety disorders; depressive disorders; primary care; patients;
epidemiology.
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In the UK, one in six adults experience clinically significant anxiety
or depressive symptoms in a given week, but only one in three with
symptoms are receiving treatment.1 The proportion of cases who
meet diagnostic criteria for a mental disorder but who do not seek
or receive treatment is called the treatment gap.2 This consists of
the proportion of cases who do not seek treatment, defined here
as the seeking gap, and the proportion of cases who seek treatment
but do not eventually receive it called the access gap.3Given the high
prevalence and burden of anxiety and depressive disorders and the
scale of the treatment gap, work is urgently required to identify bar-
riers to treatment. Individuals might not seek treatment for a variety
of reasons, including poor mental health literacy, lack of awareness
about treatment options, negative beliefs about specific treatments
and stigma.4,5 Understanding these factors will enable the develop-
ment of materials to improve mental health literacy and attitudes
toward treatments.6 It is also important to identify who public
health strategies should target, and to think about how interventions
can be tailored to different groups to encourage healthy treatment-
seeking behaviours. Some evidence has been found for demographic
associations with treatment receipt. In the UK, those who areWhite
British, female or middle-aged are most likely to report having
received treatment during a 12-month period.1 Existing studies
have largely focused on demographic associations with treatment
receipt during a discrete period, which is likely to be within the
context of a single episode of poor mental health. Generalised
anxiety disorder (GAD) and major depressive disorder (MDD)
are often chronic, and can substantially reduce quality of life and
productivity.7,8 Thus, enabling earlier treatment access has consid-
erable potential for reducing the impact of anxiety and depression
on educational and occupational outcomes. It will be necessary to
improve rates of both treatment-seeking and treatment receipt to
reduce the burden of untreated anxiety and depression. Strategies
to improve treatment-seeking, and so reduce the seeking gap, will
need to be aimed at the general population and targeted to specific
groups (e.g. men).9 In contrast, strategies to improve treatment
receipt and subsequent engagement, and so reduce the access gap,
need to be actioned by health professionals, to ensure that screening,
diagnosis and treatment selection accounts for social and cultural
differences that exist in the population.10 This can be advanced by
identifying at-risk groups, with whom further work can be done
to investigate mediating influences as psychosocial barriers to treat-
ment-seeking and treatment receipt.
Using retrospective self-report at a single time point, we tested
for associations with lifetime (i.e. ever versus never) treatment-
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seeking and treatment receipt in adults who met diagnostic criteria
for a lifetime GAD orMDDdiagnosis. Our focus on both treatment-
seeking and treatment receipt was inspired by evidence that indivi-
duals living in more socially deprived areas are more likely to have
sought, but not actually received treatment.11 Finally, there is
evidence to suggest that there are gender differences in treatment-
seeking and treatment receipt, and in alternative copingmechanisms
such as alcohol and drug use.12 To test whether sociodemographic
factors vary in their association with treatment-seeking according
to gender, we performed gender-stratified analyses. This informa-
tion might also be important when developing targeted interven-
tions for men and women. In sum, there is some evidence for
factors associated with treatment receipt during a given episode of
illness, but virtually none exploring factors associated with a lack
of ever seeking and receiving treatment. This is particularly import-
ant as public health work to promote treatment-seeking to those at
risk of not doing so could have considerable benefit both to indivi-
duals and society, by avoiding longer, more chronic illness.
Method
Participants
In total, 9 238 453 UK residents were invited to take part in the UK
Biobank study, and 503 328 individuals aged 40–70 years were
recruited at baseline (2006–2010).13 At baseline, data were collected
on sociodemographic characteristics, medical histories and health
and lifestyle-related factors. An online mental health questionnaire
(MHQ) was completed by 157 366 participants at follow-up (2016–
2017).14 Baseline participants were more likely to be older, female,
identify as White British, have favourable health status and be
from more economically advantaged neighbourhoods, compared
with the general population.15 At MHQ follow-up, respondents
were also more likely to be female, healthier and from more eco-
nomically advantaged circumstances than UK Biobank participants
who did not respond.16 Participants were considered for analysis if
they completed the MHQ, endorsed one of four screening questions
(n = 96 906) and met the full diagnostic criteria for GAD or MDD
(n = 47 013). Analyses were restricted in this manner because we
were interested in detecting factors associated with treatment-
seeking and treatment receipt in those who were most likely to
have clinically relevant treatment needs, so that findings would be
generalisable to this specific group. Thus, 123 662 participants
who completed the MHQ were ineligible and excluded from
analyses. Participants were also excluded from analyses if they
had discordant data on treatment-seeking (n = 1336), diagnoses
(n = 883) and medication use (n = 393).
Ethics and consent
UK Biobank has research ethics approval from the North West
Multi-centre Research Ethics Committee (MREC; approval
number 11/NW/0382) which covers the whole UK. It also sought
the approval in England and Wales from the Patient Information
Advisory Group (PIAG) for gaining access to information that
would allow it to invite people to participate. PIAG has since been
replaced by the National Information Governance Board for
Health & Social Care (NIGB). In Scotland, UK Biobank has
approval from the Community Health Index Advisory Group
(CHIAG). Participation in the UK Biobank is voluntary, and parti-
cipants are free to withdraw at any time. Informed written consent
was obtained by participants at baseline. The current study was per-
formed under UK Biobank application 18177. All relevant ethical
guidelines have been followed during the analysis of this data.
Measures
Symptoms of anxiety and depression: screening, diagnosis and
controlling for symptom severity
The MHQ assessed common mental health problems, including
lifetime symptoms of anxiety, depression and experiences of health-
care. Participants were initially asked whether they had experienced
‘worry for a period of 6 months or longer’, ‘worry more than most
people would in a similar situation’, ‘prolonged loss of interest in
normal activities’ or ‘prolonged feelings of sadness or depression’.
Those who endorsed an anxiety or depression screening symptom
question were subsequently asked about additional anxiety or
depression symptoms, respectively, from which diagnoses were
made with the Composite International Diagnostic Interview
Short-Form (CIDI-SF17). Screened participants (those reporting at
least one symptom) were also asked about their history of treat-
ment-seeking and treatment receipt. Therefore, if participants did
not report experience of at least one of four screening symptoms,
they were not asked about additional symptoms, nor were they
asked about their history of treatment. Of 157 366 MHQ respon-
dents, 96 096 experienced at least one of four symptom screening
items and 47 013 reported a sufficient number, severity and
impact of symptoms to meet DSM-IV diagnostic criteria for a
lifetime diagnosis of GAD (n = 11 110; prevalence = 7%) or MDD
(n = 41 971; prevalence = 27%), as determined by the CIDI-SF.
Prevalence rates estimated here are larger, but comparable to life-
time prevalence estimates reported in a population-representative
sample for GAD (prevalence = 5%) and MDD (prevalence = 21%),
respectively.14 The skip logic of CIDI-SF and self-report of symp-
toms are limitations of the study design. However, we aimed to gen-
erate a sample of individuals likely to have experienced clinical
symptom burden to assess factors that might influence treatment-
seeking. The CIDI-SF has a high classification accuracy for MDD
and GAD.17 Further information on the validity and reliability of
composite measures used by this questionnaire are detailed
elsewhere.14,17
We expected that reporting of symptom severity and impair-
ment was likely to be the strongest influence on treatment-
seeking, as these reflect a greater recognition of a need for treatment.
To estimate the effects of sociodemographic factors on treatment-
seeking and treatment receipt holding symptom severity constant,
we included a continuous measure of overall symptom severity as
a covariate in multivariable models. Some participants only com-
pleted assessment for one or other diagnosis. For each set of symp-
toms (GAD and MDD), a symptom severity score was computed as
the proportion of symptoms endorsed, weighted by the reported
impact on roles and day-to-day functioning for each set of symp-
toms. If scores for both anxiety and depression were available, the
larger of these scores was carried forward as the symptom severity
score. Symptom scores were standardised (mean 0, s.d. 1).
Treatment-related outcomes
Treatment-seeking (yes/no) was derived from participants who, in
response to the MHQ, reported on whether they had sought help
from a professional in response to their symptoms of anxiety or
depression. Treatment receipt (yes/no) was assessed in participants
who reported ‘yes’ to treatment-seeking. Those who reported receiv-
ing prescribed medication or talking therapy were defined as treat-
ment receivers, and those who received neither prescribed
medication nor talking therapy after having sought treatment
were the comparison group. Therefore, treatment receipt partici-
pants are the subset of participants that reported ‘yes’ to treat-
ment-seeking (Supplementary Figure 1 available at https://doi.org/
10.1192/bjo.2021.1012). In response to the same four symptoms,
participants were asked ‘Did you ever use the following for [the
Rayner et al
2
Downloaded from https://www.cambridge.org/core. 17 Dec 2021 at 14:18:40, subject to the Cambridge Core terms of use.
symptom] or the problems it caused?’, with the options ‘(i) Drugs or
alcohol’, ‘(ii) Unprescribed medication’ and ‘(iii) Other therapeutic
activities [mindfulness, yoga, or art classes]’. To investigate whether
use of alternative coping strategies impacts on treatment-seeking
and treatment receipt, self-medication with alcohol/drugs (item i:
yes/no) and self-help (items ii and iii combined: yes/no) were
included as explanatory variables in our analysis.
Sociodemographic factors
Sociodemographic variables were collected at baseline. For our ana-
lysis, these included age, gender, ethnicity, educational attainment,
household income, neighbourhood deprivation and social isolation.
Age at time of completing the MHQwas calculated in years. Gender
was self-reported biological sex (female/male). Given themajority of
the sample (97%) reported their ethnic background to be ‘White’ or
‘White British’, we dichotomised ethnic background into two
groups for comparison: ‘White British’ and ‘UK ethnic minority
backgrounds’. The UK ethnic minority backgrounds group included
individuals who identified as ‘Black or Black British’ (0.6%; includ-
ing Caribbean and African backgrounds), ‘mixed background’
(0.6%; including White and Black Caribbean, White and Black
African, White and Asian, and other mixed ethnic backgrounds),
‘Chinese’ (0.2%), ‘Asian’ (0.7%; including Indian, Pakistani,
Bangladeshi and other Asian backgrounds) and ‘other background’
(0.6%). We acknowledge that pooling individuals under one label is
a limitation of the study. However, this was done to preserve statis-
tical power while retaining all individuals for analysis. We used the
label ‘UK ethnic minority backgrounds’ simply to reflect the fact
that the largest proportion of individuals in the UK population iden-
tified as White British. Educational attainment was coded using six
categorical responses (‘Secondary’ denotes completion of compul-
sory secondary education, i.e. GCSE level; ‘Further’ refers to com-
pletion of further education, i.e. A-levels; ‘Vocational’ includes a
range of vocational and professional qualifications and ‘University
degree’ denotes a university-level education). We used the most
common of these categories (university degree) as the reference cat-
egory in our analyses. Annual household income was provided as
five categorical responses (<£18 000, £18 000–£30 000, £30 000–
£52 000, £52 000–£100 000, >£100 000). We used the median cat-
egory (£30 000–£52 000) as the reference category in our analyses.
Neighbourhood deprivation was assessed with the Townsend
Deprivation Index (TDI).18 TDI scores are regional and incorporate
four variables derived from census data (unemployment, car owner-
ship, homeownership and household overcrowding), which are each
standardised (mean 0, s.d. 1) and summed to give a total score. Areas
with TDI > 0 are more deprived than average, whereas areas with
TDI < 0 are more affluent. Social isolation (yes/no) was assigned to
participants who reported that they lived alone and did not partici-
pate in any social activities or received visits from friends or family
less than once per month.
Statistical analysis
Logistic regression models were fitted using glm function in R
version 3.6.3 for macOS (https://cran.r-project.org/bin/macosx/).
Based on prior literature, we selected demographic and socio-
economic factors as explanatory variables, and two variables asses-
sing alternative coping strategies (Table 1). Symptom severity scores
were included as covariates. All variables were included simultan-
eously to derive adjusted odds ratios and 95% confidence intervals
describing the extent to which these factors are associated with
treatment-seeking or treatment receipt when all other variables in
the model were held constant. Before analysis, the characteristics
of participants with complete versus missing data were compared.
Several variables differed statistically between complete cases and
those with missingness (Supplementary Tables 1 and 2). As data
was unlikely to be missing at random, multiple imputation was
not appropriate. To reduce the impact of missing data on findings,
missing data indicators were dummy-coded and included in ana-
lyses so that all participants were retained for analysis. Effect sizes
from this primary model were compared with those estimated in
complete case univariable and multivariable models. We also strati-
fied analyses by gender, to investigate whether there are gender-spe-
cific sociodemographic factors. Variables with statistically
significant gender differences were also entered into a multivariable
model that included all of the original variables, plus the relevant
variable by gender interaction terms. Effect sizes were compared
with two-sample z-tests. To assess the strength of evidence for asso-
ciation, a Bonferroni P-value was calculated with the number of
effectively independent tests, which was computed as the number
of principal components that explained 99.5% of the variance in
the correlation matrix of all explanatory variables. Variance infla-
tion factors were computed to assess multicollinearity in the multi-
variable regression models. None of the variables selected for
analysis were strongly correlated (maximum variance inflation
factor 1.14, maximum r = 0.34; Supplementary Table 7).
Results
Characteristics of the analysis sample
There were 44 810 participants (age: mean 62.3 years, s.d. 7.6 years)
with complete data on treatment-seeking and 37 346 participants
with data for treatment receipt (Supplementary Figure 1). In total,
7064 participants had missing data on at least one analysis variable.
Compared with participants with missing data, those with complete
data were younger (mean 61.8 v. 65.2 years, P < 0.001;
Supplementary Table 2), more likely to be male (33.1 v. 29.3%,
P < 0.001) and more likely to have a university degree (50.0 v.
37.8%, P < 0.001), but were less likely to have a lower household
income (annual household income < £18 000: 14.9 v. 44.0%,
P < 0.001) and be from less deprived neighbourhoods (−1.4 v.
−1.2, P < 0.001). They were more likely to have used self-help strat-
egies (27.6 v. 22.0%, P < 0.001) and self-medication with alcohol/
drugs (19.9 v. 14.8%, P < 0.001). More participants with complete
data reported seeking treatment than those with missing data
(84.2 v. 78.7%, P < 0.001). There was no evidence for differences
in treatment receipt between the analytical sample and those with
missing data (Supplementary Table 1).
The treatment gap
Overall, 83.3% had sought professional help for their symptoms
(Table 2). Of these, 89.2% had received treatment. Therefore,
74.4% of those who met criteria for a lifetime diagnosis had both
sought and received treatment. The proportion of cases in this
sample who had never sought or received treatment, defined as
the treatment gap, was 25.6%. The majority of the treatment gap
(16.7%) comprised those who never sought treatment, defined
here as the seeking gap. The access gap, the proportion of cases
who seek treatment but do not go on to receive it, comprised the
remaining 9% (Supplementary Figure 2).
Factors associated with treatment-seeking
Effect sizes and confidence intervals are reported in Table 3 and dis-
played in Figure 1. Being male was the strongest sociodemographic
factor associated with treatment-seeking, whereby men had lower
odds of seeking treatment than women (odds ratio 0.63, 95% CI
0.60–0.67; Figure 1, Table 3). Participants from UK ethnic minority
backgrounds were also less likely to seek treatment than those
Sociodemographic factors of treatment‐seeking
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identifying as White British (odds ratio 0.72, 95% CI 0.60–0.85).
Compared with those in the median annual household income
group (£30 000–£52 000), those with lower incomes were more
likely to seek treatment and those with higher incomes were less
likely to seek treatment (e.g. annual household income < £18 000:
odds ratio 1.38, 95% CI 1.25–1.53; annual household income >
£100 000: odds ratio 0.70, 95% CI 0.63–0.79). Self-help behaviour
was the strongest association with treatment-seeking from a profes-
sional (odds ratio 1.98, 95% CI 1.83–2.14). When we compared
effects estimated in the multivariable model with univariable
models, the only notable difference in effect size was for self-medi-
cation, whereby the univariable effect had an opposite direction of
effect compared with the multivariable model (multivariable odds
ratio 0.95, univariable odds ratio 1.12, Zdifference=−3.87, Pdifference =
1.00 × 10−3; Supplementary Figure 4, Supplementary Table 5).
In stratified samples, 14 562 men and 30 248 women had data
for treatment-seeking analyses. Similar to unstratified analyses,
being from an ethnic minority group was associated with reduced
odds of treatment-seeking in men and women (men: odds ratio
0.62, 95% CI 0.47–0.81; women: odds ratio 0.79, 95% CI 0.63–
0.99). Annual household income was also negatively associated
with treatment-seeking in both men and women: for annual house-
hold income <£18 000, we found an odds ratio of 1.35 (95%CI 1.14–
1.59) for men and 1.41 (95% CI 1.24–1.60) for women; and for
Table 1 Analysis variables included in logistic regression analyses examining associations with treatment-seeking and treatment receipt in a subsample
of the UK Biobank participants meeting criteria for lifetime generalised anxiety or major depressive disorder
Women (n = 30 248) Men (n = 14 562) Total (N = 44 810)
Age, years
Mean (s.d.) 62.1 (7.5) 62.7 (7.8) 62.3 (7.6)
Median 62.0 63.0 63.0
Range 46.0–80.0 46.0–80.0 46.0–80.0
UK ethnic minority
No 29 360 (97.4%) 14 111 (97.4%) 43 471 (97.4%)
Yes 794 (2.6%) 375 (2.6%) 1169 (2.6%)
Missing data 94 76 170
Annual household income
<£18 000 4767 (17.7%) 2035 (15.0%) 6802 (16.8%)
£18 000–£30 000 6750 (25.1%) 2927 (21.6%) 9677 (23.9%)
£30 000-£52 000 7656 (28.4%) 3937 (29.1%) 11 593 (28.6%)
£52 000-£100 000 6227 (23.1%) 3634 (26.8%) 9861 (24.4%)
>£100 000 1515 (5.6%) 1017 (7.5%) 2532 (6.3%)
Missing data 3333 1012 4345
Educational attainment
Secondary 7501 (26.6%) 3121 (23.2%) 10 622 (25.5%)
Further 4556 (16.1%) 1859 (13.8%) 6415 (15.4%)
Vocational 2655 (9.4%) 1600 (11.9%) 4255 (10.2%)
Degree 13 512 (47.9%) 6859 (51.0%) 20 371 (48.9%)
Missing data 2024 1123 3147
Neighbourhood deprivation
Mean (s.d.) −1.4 (2.9) −1.3 (3.1) −1.4 (3.0)
Median −2.1 −2.1 −2.1
Range −6.3 to 11.0 −6.3 to 10.5 −6.3 to 11.0
Missing data 48 30 78
Social isolation
No 26 992 (90.5%) 12 649 (88.2%) 39 641 (89.8%)
Yes 2826 (9.5%) 1700 (11.8%) 4526 (10.2%)
Missing data 430 213 643
Self-help
No 21 155 (69.9%) 11 676 (80.2%) 32 831 (73.3%)
Yes 9093 (30.1%) 2886 (19.8%) 11 979 (26.7%)
Self-medication with alcohol or drugs
No 25 306 (83.7%) 10 950 (75.2%) 36 256 (80.9%)
Yes 4942 (16.3%) 3612 (24.8%) 8554 (19.1%)
Lifetime symptom severity
Mean (s.d.) 2.3 (0.6) 2.3 (0.6) 2.3 (0.6)
Median 2.4 2.4 2.4
Range 0.0–3.0 0.0–3.0 0.0–3.0
Missing data 13 5 18
Data are displayed as n (%), unless otherwise indicated. Neighbourhood deprivation is measured using the Townsend Deprivation Index. Here, positive scores reflect greater neighbourhood
deprivation than the UK average (0). The analysis sample has a negative mean deprivation score, indicating that on average this sample is from more affluent neighbourhoods than the
average UK population. Lifetime symptom severity score is calculated as the proportion of Composite International Diagnostic Interview Short-Form symptoms endorsed, weighted by
overall functional impairment; scores were standardised to have a mean of 0 and s.d. of 1 in all analyses
Table 2 Treatment-seeking and treatment receipt outcomes in a
subsample of the UK Biobank participants meeting criteria for lifetime




(n = 14 562)
Total
(N = 44 810)
Treatment-seeking
No 4302 (14.2%) 3163 (21.7%) 7465 (16.7%)
Yes 25 946 (85.8%) 11 399 (78.3%) 37 345 (83.3%)
Treatment receipt
No 2637 (10.2%) 1387 (12.2%) 4024 (10.8%)
Yes 23 309 (89.8%) 10 012 (87.8%) 33 321 (89.2%)
Missing data 4302 3163 7465
Total cases treated
No 6939 (22.9%) 4550 (31.2%) 11 489 (25.6%)
Yes 23 309 (77.1%) 10 012 (68.8%) 33 321 (74.4%)
Rayner et al
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annual household income >£100 000, we found an odds ratio of 0.66
(95% CI 0.56–0.78) for men and 0.73 (95% CI 0.63–0.86) for
women.
There were four statistically significant gender differences in
effect sizes for self-medication, self-help, educational attainment
and age (Figure 1, Supplementary Table 5). Self-medication with
alcohol was associated with lower odds of treatment-seeking in
men, but not in women (men: odds ratio 0.85, 95% CI 0.76–0.94;
women: odds ratio 1.07, 95% CI 0.96–1.20; Zdifference = 3.05;
Pdifference = 2.29 × 10
−3). Self-help behaviour was positively asso-
ciated with treatment-seeking in both genders, but had a larger
effect in men than women (men: odds ratio 2.51, 95% CI 2.19–
2.89; women: odds ratio 1.76, 95% CI 1.60–1.93; Zdifference =
−4.18; Pdifference = 2.92 × 10
−5). Only one educational effect had
gender differences, which was the comparison between having a
university degree and a vocational qualification. Here, men who
had a vocational qualification were less likely to seek treatment
(odds ratio 0.77, 95% CI 0.67–0.90), whereas there was no clear
effect of having a vocational qualification for women (odds ratio
1.07, 95% CI 0.93–1.23; Zdifference = 3.16; Pdifference = 1.58 × 10
−3).
Age showed no association with treatment-seeking in the full
sample, but showed opposite effects between gender. Older men
were more likely to have sought treatment than younger
men (odds ratio 1.01 per year, 95% CI 1.01–1.02), but younger
women were more likely to have sought treatment than older
women (odds ratio 0.99 per year, 95% CI 0.99–1.00; Zdifference =
−4.48; Pdifference = 7.50 × 10
−6). Given that age, educational attain-
ment, self-help and self-medication had statistically significant
gender differences, we ran an additional multivariable model,
which included these variable×gender interaction terms. Estimates
from this model are provided in Supplementary Table 7.
Factors associated with treatment receipt
Of treatment-seekers (n = 37 346), 89.2% reported receiving treat-
ment. The strongest factor associated with treatment receipt was
ethnicity. Specifically, individuals from ethnic minority groups in
the UK were less likely to receive treatment than those of White
British ethnicity (odds ratio 0.59, 95% CI 0.48–0.72; Figure 1,
Table 3). Male gender was also associated with lower odds of receiv-
ing treatment (odds ratio 0.84, 95% CI 0.77–0.90). Compared with
having a university degree, having completed secondary education,
further education and vocational qualification were all associated
with lower odds of receiving treatment (odds ratio 0.83–0.85,
95%CI[minimum, maximum] 0.73–0.94). Factors associated with increased
odds of treatment receipt were lower than median annual household
income (odds ratio 1.19–1.35, 95% CI[minimum, maximum] 1.07–1.53),
neighbourhood deprivation (odds ratio 1.03 per unit change,
95% CI 1.01–1.04) and use of self-help behaviour strategies (odds
ratio 1.28, 95% CI 1.17–1.39). There were no notable differences
in effect sizes between multivariable and univariable models
(Supplementary Table 5).
In stratified analyses of treatment receipt, there were 11 399
men and 25 946 women. Similar to the main analysis, factors asso-
ciated with treatment receipt in women included ethnicity (odds
ratio 0.60, 95% CI 0.47–0.77), educational attainment other than a
university degree (odds ratio 0.83, 95% CI[minimum, maximum] 0.66–
1.00) and neighbourhood deprivation (odds ratio 1.04, 95% CI
1.02–1.05). Although these effects were of similar size in men, for
some, the strength of evidence was weaker (ethnicity: odds ratio
0.68, 95% CI 0.39–0.85; education: odds ratio 0.86, 95% CI 0.75–
0.99; neighbourhood deprivation: odds ratio 1.01, 95% CI 0.99–
1.04). This is likely because stratifying the sample by gender resulted
in a substantial difference in sample size and statistical power
between strata. However, there were no gender differences in
factors associated with treatment receipt (maximum Zdifference =
−1.94; Pdifference = 0.05; Supplementary Table 5).
Discussion
Main findings
We estimated the proportion of UK Biobank participants who never
sought or received treatment despite meeting criteria for lifetime
Table 3 Factors associated with treatment-seeking and treatment receipt in UK Biobank participants meeting CIDI-SF criteria for a lifetime diagnosis of
generalised anxiety or major depressive disorder
Treatment-seeking Treatment receipt
Variable Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Age (per year) 1.00 [1 to 1.01] 1.93e-01 1.00 [0.99 to 1] 3.84e-01
Gender (reference: Female)
Male 0.63 [0.6 to 0.67] 6.80e-52 0.84 [0.77 to 0.9] 4.21e-06
UK ethnic minority (reference: no)
Yes 0.72 [0.6 to 0.85] 1.37e-04 0.59 [0.48 to 0.72] 3.80e-07
Missing data 0.63 [0.39 to 1.04] 6.98e-02 0.78 [0.4 to 1.51] 4.55e-01
Annual household income (reference: £30 000–£52 000)
<£18 000 1.38 [1.25 to 1.53] 5.70e-10 1.35 [1.19 to 1.53] 1.79e-06
£18 000–£30 000 1.16 [1.07 to 1.26] 3.69e-04 1.19 [1.07 to 1.31] 8.67e-04
£52 000–£100 000 0.90 [0.83 to 0.97] 4.32e-03 0.95 [0.86 to 1.04] 2.57e-01
>£100 000 0.70 [0.63 to 0.79] 1.80e-09 1.12 [0.95 to 1.31] 1.86e-01
Educational attainment (reference: university degree)
Secondary 0.96 [0.9 to 1.04] 3.27e-01 0.85 [0.78 to 0.93] 5.12e-04
Further 1.03 [0.95 to 1.13] 4.52e-01 0.85 [0.76 to 0.94] 1.92e-03
Vocational 0.92 [0.83 to 1.02] 1.13e-01 0.83 [0.73 to 0.94] 3.04e-03
Neighbourhood deprivation (per s.d.) 1.01 [1 to 1.02] 9.01e-02 1.03 [1.01 to 1.04] 1.52e-04
Social isolation (reference: no)
Yes 0.91 [0.83 to 1.01] 6.49e-02 1.12 [0.99 to 1.28] 7.71e-02
Missing data 0.78 [0.48 to 1.28] 3.26e-01 1.54 [0.71 to 3.35] 2.71e-01
Self-help (reference: no)
Yes 1.98 [1.83 to 2.14] 1.00e-66 1.28 [1.17 to 1.39] 1.92e-08
Self-medication with alcohol or drugs (reference: no)
Yes 0.95 [0.88 to 1.02] 1.82e-01 1.09 [0.99 to 1.2] 7.34e-02
Odds ratios, 95% confidence intervals and P-values estimated from multivariable regression analyses. CIDI-SF, Composite International Diagnostic Interview Short-Form.
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anxiety or depressive disorder diagnosis, defined here as the lifetime
treatment gap. In this sample, the lifetime treatment gap was 25.6%.
This estimate reflects a lack of treatment access over the life course.
In contrast, previous point prevalence estimates of 60–70%1,19 were
obtained from studying shorter time intervals, which are more likely
to be within the context of a single period of poor mental health.
Notably, participants in the UK Biobank are middle-aged or
older, and therefore are more likely to have received treatment at
some point in their lives than younger adults. Furthermore, the
socioeconomic circumstances of the UK Biobank participants are
more advantaged than the general population, which may also
explain differences between the estimates. We also reported
factors associated with lifetime treatment-seeking and treatment
receipt. In these data, being male or from an ethnic minority
group in the UK context were the strongest sociodemographic
factors associated with treatment-seeking and treatment receipt,
respectively.20 These factors have been associated with treatment
receipt at the time of treatment need.1
Gender differences in treatment-seeking for mental health pro-
blems have been widely discussed. Being male is associated with
negative treatment-seeking attitudes21 and low willingness to seek
treatment.22 Likely mediators of these attitudes include male social-
isation, masculine traits and associated self-stigma,23,24 poor mental
health literacy25 and differences in coping strategies (e.g. higher
likelihood to self-medicate with alcohol/drugs).12,26When we strati-
fied our analyses by gender, the most notable gender differences
were the effects of alternative coping strategies. Men who reported
self-medicating with alcohol/drugs were less likely to have sought
treatment for their anxiety or depression. Alcohol use problems
and MDD commonly co-occur.27 Indeed, the participants of this
study who reported self-medicating with alcohol/drugs could have
also had co-occurring substance-related problems. More work is
required to better understand the relationship between depression,
self-medication and substance related problems. If treatment receipt
for depression moderates the relationship between depression and
alcohol use problems, improving treatment-seeking and treatment
receipt for anxiety and depression could be an important target
for reducing the collective burden from these disorders.28 Overall,
reported use of a self-help strategy was the strongest predictor of




Self-medication with alcohol or drugs
0.5 0.6 0.8 1 1.2 1.6 2 0.5 0.6 0.8 1 1.2 1.6 2
Odds ratio (log scale) [95% CI]
Vocational
Further











All Men Women Bonferroni P < 0.0033 P > 0.0033
Fig. 1 Factors associated with treatment seeking and receipt in UK Biobank participants meeting criteria for lifetime generalised anxiety or
major depressive disorder. Odds ratios, 95% confidence intervals and P-values estimated from multivariable regression analyses of treatment
seeking and treatment receipt in the full sample (green; n = 44 810 and 37 346), in males (blue; n = 10 737 and 8 733) and in females (yellow;
n = 22 967 and 20 207).
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However, it is difficult to determine the direction of effect. Use of
self-help strategies might reflect good mental health literacy and
increased likelihood of seeking treatment. Equally, self-help activ-
ities are often prescribed by clinicians. Nonetheless, it could
suggest a general willingness to seek and try out an intervention.
Preliminary research suggests those who struggle more with
stigma are more likely to engage with online self-help interventions
than to seek help.29,30 Such resources may act as a gateway to profes-
sional help. Educational interventions have been shown to improve
treatment-seeking attitudes and behaviours, specifically in men.9
Individuals fromUKminority ethnic groups were also less likely
to seek and receive treatment thanWhite British participants in this
study. Qualitative work with participants from UK minority ethnic
groups identified personal–environmental factors (health literacy,
social support, culture and associated stigma) and patient–provider
relationship factors (wait times, communication difficulties and dis-
crimination) as barriers to treatment for them.10 More work is
required to understand the role of cultural, systematic and clinician
factors on the detection and appropriate treatment of mental health
problems for individuals exposed to minority stress and factors spe-
cific to different ethnic groups. The small proportion of participants
from different ethnic groups in our sample meant we were unable to
investigate the differences between different ethnic groups or the
specific socioeconomic factors associated with treatment receipt,
which is a key limitation of the study. Psychosocial barriers are
likely to be the mediating factors between sociodemographic
factors and treatment-seeking and treatment receipt. In the UK,
research shows these barriers include stigmatising attitudes
toward mental health problems and treatments, lack of trust in
current treatments4,5 and perceived clinician biases.10 In our ana-
lysis, men and individuals from ethnic minority groups in the UK
are at risk of not accessing treatment, and this may be a result of
them experiencing these barriers.
With regard to socioeconomic factors, a more complex pattern
emerged. Higher income was associated with reduced odds of treat-
ment-seeking and treatment receipt and neighbourhood depriv-
ation was associated with increased odds of treatment receipt. The
finding that more affluent individuals were less likely to seek and
receive treatment is surprising. Previous work shows that although
those with more advantageous socioeconomic circumstances are
less likely to seek treatment overall, they are more likely to receive
it if they do seek it – referred to as the ‘inverse care law’.11,31 The
difference observed here may reflect the high sociodemographic
profile of this sample compared with the general population of
the UK, as those from less advantaged socioeconomic backgrounds
are not well-represented in the sample. It might also be the case that
more affluent participants in our sample have stronger social
support networks, which helps to alleviate symptoms and the
need for treatment.32 Compared with having a university-level edu-
cation, secondary, further and vocational educational levels were all
associated with lower odds of receiving treatment after having
sought it. University-level education is associated with improved
mental health literacy and reduced stigmatising attitudes toward
mental health conditions and treatments.33,34 Therefore, those
with university level education might be better equipped to recog-
nise and communicate their symptoms and needs effectively, or
more open to engaging with treatments.
Limitations
The characteristics of the UK Biobank sample and the cross-
sectional study design mean that interpretations of these findings
should be made with caution. Selection bias in the context of popu-
lation-based cohort studies in general, and in the UK Biobank spe-
cifically, is a key limitation that has been widely discussed.14–16
Especially relevant for this study, the subsample of UK Biobank par-
ticipants who completed the follow-upMHQhavemore advantaged
socioeconomic circumstances, including higher educational attain-
ment, than the general UK population.14 Participation was also
negatively associated with being male, having mental or physical
disorder diagnoses, being a smoker and having a higher body
mass index, and positively associated with having a university
degree and having a relative who has had severe depression.16
Importantly, some of these factors are also associated with access
to treatment,3,11 and were associated with treatment-seeking or
treatment receipt in our analyses. However, although the lack of
representativeness has been shown to bias estimates of prevalence,
analyses using large samples containing such biases have been
shown to produce risk factor associations with outcomes that are
generalisable to the population under study.15,35 For example,
cardiovascular-related risk factor associations in the UK Biobank
and a UK representative sample (Health Surveys for England and
the Scottish Health Surveys consortium) had an overall effect size
ratio close to unity, despite the differences in sample selection.36
Although associations detected in non-random samples should be
interpreted with caution, where data on outcomes of interest
exists in large biobank data-sets, exploratory analyses such as ours
can be used to inform future analyses and replication efforts in rep-
resentative samples.
Our focus on lifetime outcomes allowed us to detect factors
associated with treatment-seeking and treatment receipt that are
potentially pervasive across the lifespan. However, our analysis
was cross-sectional and the sample was age variable. It is reasonable
to expect that the probability of seeking treatment would be
higher in older participants, because of the increased probability
of an event over time, yet we did not observe an effect of age on
access to treatment. This is potentially because of changes in the
availability and knowledge of mental healthcare over time, or
recall difficulties in older participants. The participants included
in this analysis were older than the general population, and it is
likely some will have experienced their symptoms earlier in life,
when both mental health literacy and access to treatment were
less common than they are now. It is also plausible that treatment
undertaken earlier in life for older participants would not be as
readily recalled as more recent treatment undertaken by younger
participants. The potentially opposite effects of ‘probability of
access over time’ and ‘change in resources over time’ could poten-
tially induce a cohort effect, and therefore, future analyses of treat-
ment access may benefit from stratification by age or longitudinal
study designs.
The clinical utility of public health interventions aiming to
predict or encourage treatment-seeking relies on several assump-
tions. One is that such interventions are effective. However, there
is mixed evidence in support of help-seeking interventions. A sys-
tematic review found that although such initiatives had small
effects on improving treatment-seeking attitudes, they had no
effect on treatment-seeking behaviour.37 Therefore, more work is
required to improve the efficacy of treatment-seeking interventions,
and to assess the long term benefits following them. Another
assumption is that everyone who experiences symptoms needs
and will benefit from treatment, and furthermore, that healthcare
services have capacity to see and treat more patients. Many indivi-
duals with anxiety and depression spontaneously remit over time,38
some who receive treatment do not respond.39 Further, for those
who do seek psychological therapies, there are often long wait-
lists, the length of which has been shown to predict poorer out-
comes.40 Therefore, efforts to improve treatment-seeking must
also be matched with increased availability of treatment, and such
efforts need to be targeted at those who are unlikely to remit
without intervention.
Sociodemographic factors of treatment‐seeking
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Future directions
Longitudinal studies are needed to assess whether treatment-
seeking and treatment receipt moderate trajectories of symptoms
over time, as well as educational, occupational and life outcomes,
to determine how effective interventions are likely to be.
Educational and occupational outcomes could be assessed in longi-
tudinal cohorts of children and adolescents, and later-life outcomes
assessed in older adult samples. Later-life outcomes could include
long-term prognosis (i.e. course and chronicity of symptoms), add-
itional mental and physical diagnoses, and negative outcomes such
as alcohol and substance use disorders and suicide. Although there
was information available on the broad category of treatment
received (medication and/or talking therapy), we focused on the
receipt of any kind of treatment. Future studies could investigate
treatment access in more detail.
Our findings suggest that out of all of the individuals who
reported sufficient number and burden of anxiety or depressive
symptoms to meet diagnostic criteria, men and individuals from
ethnic minority backgrounds were less likely to access treatment.
Psychosocial barriers are likely to be the mediating factors between
sociodemographic variables and treatment-seeking and treatment
receipt. In the UK, research shows that these barriers include stigma-
tising attitudes toward mental health problems and treatments, lack
of trust in current treatments4,5 and perceived clinician biases.10
Men and individuals from ethnic minority backgrounds are at
increased risk of not accessing treatment in our analyses, and this
may be because they are experiencing these barriers more frequently.
This includes not receiving treatment even after having sought it.
Thus, clinicians also have an important role to play in reducing the
access gap (9% in this sample), by offering targeted information
and support to treatment-seeking individuals who are at risk of
experiencing stigma or discrimination. Much work is needed to
investigate barriers to treatment for marginalised populations, as
research grouping participants together is not sufficient to make
evidence-based conclusions to adequately serve the many groups.
In conclusion, the current findings represent an important step
toward identifying groups of individuals at risk of not seeking or
receiving treatment for anxiety and depression. Future work to inves-
tigate both the specific psychosocial factors that mediate these asso-
ciations, and targeted interventions attempting to address them, are
likely to yield significant benefit for individuals, families and
society, by reducing the burden of untreated anxiety and depression.
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